|
Volumn 39, Issue 1, 2002, Pages 117-129
|
Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart
a a a a a |
Author keywords
Adenosine kinase; Adenosine receptor; Ischemia; Mouse; Reperfusion
|
Indexed keywords
2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE);
2 CHLORO N6 (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE;
4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER;
6 N CYCLOPENTYLADENOSINE;
8 (4 SULFOPHENYL)THEOPHYLLINE;
ADENINE DERIVATIVE;
ADENOSINE;
ADENOSINE A1 RECEPTOR;
ADENOSINE A1 RECEPTOR AGONIST;
ADENOSINE A2A RECEPTOR;
ADENOSINE A2A RECEPTOR AGONIST;
ADENOSINE A3 RECEPTOR;
ADENOSINE A3 RECEPTOR AGONIST;
ADENOSINE DERIVATIVE;
ADENOSINE KINASE;
CARBOXYLIC ACID DERIVATIVE;
CYCLOHEXANE DERIVATIVE;
METHYL 4 [3 [9 [5 (N ETHYLCARBAMOYL) 3,4 DIHYDROXYOXOLAN 2 YL] 6 AMINOPURIN 2 YL]PROP 2 YNYL]CYCLOHEXANE CARBOXYLATE;
TUBERCIDIN DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
CORONARY ARTERY PRESSURE;
DIASTOLE;
DRUG EFFECT;
ENZYME INHIBITION;
HEART FUNCTION;
HEART MUSCLE CONTRACTILITY;
HEART MUSCLE CONTRACTURE;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REPERFUSION;
HEART PROTECTION;
ISOLATED HEART;
MOUSE;
NONHUMAN;
PERFUSION PRESSURE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REPERFUSION INJURY;
TREATMENT OUTCOME;
ADENOSINE;
ADENOSINE KINASE;
ANIMALS;
BLOOD PRESSURE;
CARDIOTONIC AGENTS;
CORONARY CIRCULATION;
FEMALE;
MALE;
MICE;
MICE, INBRED C57BL;
MICE, TRANSGENIC;
MYOCARDIAL REPERFUSION INJURY;
MYOCARDIUM;
NECROSIS;
PHOSPHORYLATION;
RECEPTOR, ADENOSINE A2A;
RECEPTORS, PURINERGIC P1;
VASODILATOR AGENTS;
VENTRICULAR PRESSURE;
|
EID: 0036140204
PISSN: 01602446
EISSN: None
Source Type: Journal
DOI: 10.1097/00005344-200201000-00013 Document Type: Article |
Times cited : (51)
|
References (49)
|